{"doc_id": "si-2023-0671-reg-1", "parent_doc_id": "si-2023-0671", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "1. These Regulations may be cited as the European Union (National", "text_raw": "1. These Regulations may be cited as the European Union (National \nResearch Ethics Committees for Clinical Investigations of Medical Devices) \nRegulations 2023. \n\nCommencement", "text_norm": "1 regulation may cited european union (national research ethic committee clinical investigation medical devices) regulation 2023 commencement", "start_char": 965, "end_char": 1143, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-2", "parent_doc_id": "si-2023-0671", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "2. These Regulations come into operation on 1 January 2024.", "text_raw": "2. These Regulations come into operation on 1 January 2024. \n\nInterpretation", "text_norm": "2 regulation come operation 1 january 2024 interpretation", "start_char": 1143, "end_char": 1222, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-3", "parent_doc_id": "si-2023-0671", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "3. (1) In these Regulations—", "text_raw": "3. (1) In these Regulations— \n\n“Act of 2007 means the Medical Practitioners Act 2007 (No. 25 of 2007); \n\n“application” means an application made by a sponsor to a National REC \nCommittee, via the National Office, for a National REC review of a clinical \ninvestigation to be conducted in the State under the EU Regulation or for a \nNational REC review of a substantial modification of such a clinical \ninvestigation; \n\n“Authority” means the Health Products Regulatory Authority; \n\n“clinical investigation site” means a hospital, clinic, nursing home, health \ncentre, surgery or other establishment or facility at or from which a clinical \ninvestigation, or any part of such a clinical investigation, is conducted; \n\n“EU Regulation” means Regulation (EU) 2017/745 of the European Parliament \nand of the Council of 5 April 20171, as amended by Regulation (EU) 2020/561 \nof the European Parliament and of the Council of 23 April 20202 and \n\n1 OJ No. L 117, 5.5.2017, p. 1. \n2 OJ No. L 130, 24.4.2020, p. 18. \n3 OJ No. L 80, 20.3.2023, p. 24. \n\nNotice of the making of this Statutory Instrument was published in \n\"Iris Oifigiúil\" of 22nd December, 2023. \n\n \n \n \n \n \n \n \n \n\f[671] 3 \n\nRegulation (EU) 607/2023 of the European Parliament and of the Council of 15 \nMarch 202343; \n\n“expert member” means a member of a National REC who is – \n\n(a) \n\n(b) \n\na practising or retired health practitioner, \n\na person who has professional qualifications or experience \nrelating to the conduct of, or use of statistics in clinical research, \nunless the said qualifications or experience relate only to the \nethics of clinical research or medical treatment, or \n\n(c) \n\na person who is involved in the promotion, organisation or \nconduct of clinical research; \n\n“Head of the National Office” has the meaning assigned to it by Regulation 4; \n\n“health practitioner” has the same meaning as it has in the Health Identifiers \nAct 2014 (No. 15 of 2014); \n\n“investigator” for the purposes of the EU Regulation and these Regulations \nmeans a person who meets the qualification requirements which are set out in \nRegulation 9 of the Medical Devices Regulations 2021 (S.I. 261 of 2021); \n\n“in writing” includes by electronics means; \n\n“lay member” means a member of a National REC who is not an expert member; \n\n“legally designated representative”, for the purposes of these Regulations and \nthe EU Regulation only, and in relation to clinical investigations only, means: \n\n(a) \n\nin relation to an incapacitated subject who is, or is being \nconsidered as, a subject for a clinical investigation, means- \n\n(i) \n\na person, other than a person connected with the conduct \nof the clinical investigation, who by virtue of his or her \nfamily or other personal relationship with the individual: \n\n(aa) can provide the best interpretation of the will and \npreferences relating to healthcare of the individual \nbased on their knowledge of the individual, and \n\n(bb) is available and willing to act for that purpose, or \n\n(ii) \n\nif there is no such person, the medical practitioner \nprimarily responsible for the medical treatment provided \nto the individual where he or she- \n\n(aa) can provide the best interpretation of the will and \npreferences relating to healthcare of the individual \nbased on their knowledge of the individual, \n\n(bb) is not involved in the conduct of the clinical \n\ninvestigation, \n\n(cc) \n\nis of the view that participation in the clinical \ninvestigation will not prejudice the health and \nwellbeing of the individual, and \n\n \n \n \n \n\f4 [671] \n\n(dd) is available and willing to act for that purpose, and \n\n(b) \n\nin relation to a minor who is, or is being considered as, a subject \nfor a clinical investigation means a guardian within the meaning \nthe Guardianship of Infants Act, 1964 (No. 7 of 1964); \n\n“Minister” means the Minister for Health; \n\n“‘minor’ means a person who has not attained the age of 16 years; \n\n“National Office” has the meaning assigned to it by Regulation 4;”. \n\n“National REC” has the meaning assigned to it by Regulation 11; \n\n“opinion” means an opinion of a National REC expressed for the purposes of \nthese Regulations and the EU Regulation; \n\n“Regulations of 2021” means the European Union (National Research Ethics \nCommittee for Clinical Investigations of Medical Devices) Regulations 2021 \n(S.I. 260 of 2021); \n\n(2) A word or expression which is used in these Regulations and which is \nalso used in the EU Regulation has, unless the context otherwise requires, the \nsame meaning in these Regulations as it has in the EU Regulation. \n\nPART 2 \n\nNATIONAL OFFICE FOR NATIONAL RESEARCH ETHICS \nCOMMITTEES FOR CLINICAL INVESTIGATIONS OF MEDICAL \nDEVICES \n\nEstablishment of National Office", "text_norm": "3 (1) regulations-- act 2007 mean medical practitioner act 2007 (no 25 2007) application mean application made sponsor national rec committee via national office national rec review clinical investigation conducted state eu regulation national rec review substantial modification clinical investigation authority mean health product regulatory authority clinical investigation site mean hospital clinic nursing home health centre surgery establishment facility clinical investigation part clinical investigation conducted eu regulation mean regulation (eu) 2017 745 european parliament council 5 april 20171 amended regulation (eu) 2020 561 european parliament council 23 april 20202 1 oj no l 117 5.5.2017 p 1 2 oj no l 130 24.4.2020 p 18 3 oj no l 80 20.3.2023 p 24 notice making statutory instrument published iris oifigiuil 22nd december 2023 671 3 regulation (eu) 607 2023 european parliament council 15 march 202343 expert member mean member national rec - (a) (b) practising retired health practitioner person professional qualification experience relating conduct use statistic clinical research unless said qualification experience relate ethic clinical research medical treatment (c) person involved promotion organisation conduct clinical research head national office meaning assigned regulation 4 health practitioner meaning health identifier act 2014 (no 15 2014) investigator purpose eu regulation regulation mean person meet qualification requirement set regulation 9 medical device regulation 2021 (s.i 261 2021) writing includes electronics mean lay member mean member national rec expert member legally designated representative purpose regulation eu regulation relation clinical investigation mean (a) relation incapacitated subject considered subject clinical investigation means- (i) person person connected conduct clinical investigation virtue family personal relationship individual (aa) provide best interpretation preference relating healthcare individual based knowledge individual (bb) available willing act purpose (ii) person medical practitioner primarily responsible medical treatment provided individual she- (aa) provide best interpretation preference relating healthcare individual based knowledge individual (bb) involved conduct clinical investigation (cc) view participation clinical investigation prejudice health wellbeing individual 4 671 (dd) available willing act purpose (b) relation minor considered subject clinical investigation mean guardian within meaning guardianship infant act 1964 (no 7 1964) minister mean minister health minor mean person attained age 16 year national office meaning assigned regulation 4  national rec meaning assigned regulation 11 opinion mean opinion national rec expressed purpose regulation eu regulation regulation 2021 mean european union (national research ethic committee clinical investigation medical devices) regulation 2021 (s.i 260 2021) (2) word expression used regulation also used eu regulation unless context otherwise requires meaning regulation eu regulation part 2 national office national research ethic committee clinical investigation medical device establishment national office", "start_char": 1222, "end_char": 5921, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-4", "parent_doc_id": "si-2023-0671", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "4. (1) (a) There shall be a unit within the Health Research Board", "text_raw": "4. (1) (a) There shall be a unit within the Health Research Board \n\nwhich shall be known as the National Office for National Research Ethics \nCommittees for Clinical Investigations of Medical Devices (in these Regulations \nreferred to as the “National Office”), which shall, subject to subparagraph (b), \nbe a constituent part of the Health Research Board. \n\n(b) The National Office shall, subject to these Regulations, be \n\nindependent in the performance of its functions. \n\n(2) The National Office shall be headed by a person who shall, in these \n\nRegulations, be referred to as the “Head of the National Office”. \n\n(3) The Head of the National Office shall be appointed by the Health \nResearch Board and he or she shall hold office and be paid such remuneration \nand any allowances for expenses that may, with the approval of the Minister, \nbe determined by the Health Research Board, given with the consent of the \nMinister for Public Expenditure and Reform. \n\n(4) The Health Research Board may dismiss the Head of the National \n\nOffice where it is satisfied that the Head of the National Office – \n\n(a) \n\nhas become \nincapable \nperforming the functions of the office, \n\nthrough \n\nill health of effectively \n\n \n \n \n \n\f[671] 5 \n\n(b) \n\nis adjudicated bankrupt, \n\n(c) \n\nis convicted of a criminal offence, \n\n(d) has, without reasonable excuse, failed to discharge his or her \nfunctions for a continuous period of 3 months beginning not \nearlier than 6 months before the day of dismissal, or \n\n(e) \n\nshould be dismissed for any other stated reason. \n\n(5) The Head of the National Office and the officers of the National Office \nshall be employees of the Health Research Board which shall determine their \nconditions of employment and duties, and the officers of the National Office \nshall report to the Head of the National Office in relation to the performance of \nthose duties. \n\nGovernance of National Office", "text_norm": "4 (1) (a) shall unit within health research board shall known national office national research ethic committee clinical investigation medical device (in regulation referred national office ) shall subject subparagraph (b) constituent part health research board (b) national office shall subject regulation independent performance function (2) national office shall headed person shall regulation referred head national office  (3) head national office shall appointed health research board shall hold office paid remuneration allowance expense may approval minister determined health research board given consent minister public expenditure reform (4) health research board may dismiss head national office satisfied head national office - (a) become incapable performing function office ill health effectively 671 5 (b) adjudicated bankrupt (c) convicted criminal offence (d) without reasonable excuse failed discharge function continuous period 3 month beginning earlier 6 month day dismissal (e) dismissed stated reason (5) head national office officer national office shall employee health research board shall determine condition employment duty officer national office shall report head national office relation performance duty governance national office", "start_char": 5921, "end_char": 7835, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-5", "parent_doc_id": "si-2023-0671", "section_id": "reg-5", "section_label": "Regulation 5.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "5. (1) The Health Research Board shall, to the extent that it is necessary", "text_raw": "5. (1) The Health Research Board shall, to the extent that it is necessary \nand appropriate in order to assist the National Office in performing its \nfunctions efficiently and effectively, provide administrative and operational \nsupport to the National Office. \n\n(2) The Health Research Board shall, not later than the 30th day of June \neach year, submit a statement to the Minister setting out the funding required \nfor the following financial year to provide the administrative and operational \nsupport referred to in paragraph (1). \n\nInformation on the internet in relation to National Office", "text_norm": "5 (1) health research board shall extent necessary appropriate order assist national office performing function efficiently effectively provide administrative operational support national office (2) health research board shall later 30th day june year submit statement minister setting funding required following financial year provide administrative operational support referred paragraph (1) information internet relation national office", "start_char": 7835, "end_char": 8433, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-6", "parent_doc_id": "si-2023-0671", "section_id": "reg-6", "section_label": "Regulation 6.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "6. The National Office shall maintain, and update in a timely manner, a", "text_raw": "6. The National Office shall maintain, and update in a timely manner, a \n\nwebsite containing the following – \n\n(a) \n\ncontact details for the National Office, \n\n(b) \n\ncontact details for each National REC, \n\n(c) \n\n(d) \n\nthe names of the members of each National REC and their \nidentification as expert members or lay members, \n\ninformation on the National Office’s operational processes and \nprocedures, \n\n(e) minutes of the meetings of each National REC, \n\n(f) \n\n(g) \n\n(h) \n\nthe decisions given under Regulation 21 by a National REC, \n\ninformation on appeals and complaints procedures, \n\nany other matters that the National Office considers appropriate. \n\nDevelopment and support of National RECs", "text_norm": "6 national office shall maintain update timely manner website containing following - (a) contact detail national office (b) contact detail national rec (c) (d) name member national rec identification expert member lay member information national office operational process procedure (e) minute meeting national rec (f) (g) (h) decision given regulation 21 national rec information appeal complaint procedure matter national office considers appropriate development support national recs", "start_char": 8433, "end_char": 9132, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-7", "parent_doc_id": "si-2023-0671", "section_id": "reg-7", "section_label": "Regulation 7.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "7. The Head of the National Office shall, subject to any general directions", "text_raw": "7. The Head of the National Office shall, subject to any general directions \n\nby the Minister – \n\n(a) \n\ntake such actions and initiatives as he or she considers \nappropriate in order to assist in the development of high \nperforming National RECs, \n\n \n \n \n \n\f6 [671] \n\n(b) provide such administrative and other support as he or she \nconsiders necessary to enable National RECs to perform their \nfunctions efficiently and effectively. \n\nEngagement by National Office with National RECs to ensure efficient \nand effective National REC system", "text_norm": "7 head national office shall subject general direction minister - (a) take action initiative considers appropriate order assist development high performing national recs 6 671 (b) provide administrative support considers necessary enable national recs perform function efficiently effectively engagement national office national recs ensure efficient effective national rec system", "start_char": 9132, "end_char": 9673, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-8", "parent_doc_id": "si-2023-0671", "section_id": "reg-8", "section_label": "Regulation 8.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "8. The National Office shall engage with National RECs to ensure an", "text_raw": "8. The National Office shall engage with National RECs to ensure an \neffective National REC system and may, where it considers it appropriate to do \nso, develop best practice procedures for the purpose of assisting National RECs \nin performing their functions. \n\nAdvice, educational outreach and training for National RECs", "text_norm": "8 national office shall engage national recs ensure effective national rec system may considers appropriate develop best practice procedure purpose assisting national recs performing function advice educational outreach training national recs", "start_char": 9673, "end_char": 9998, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-9", "parent_doc_id": "si-2023-0671", "section_id": "reg-9", "section_label": "Regulation 9.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "9. The National Office shall provide such advice and training as it", "text_raw": "9. The National Office shall provide such advice and training as it \n\nconsiders \n\nappropriate for National RECs in relation to the performance of their functions. \n\nAnnual Report", "text_norm": "9 national office shall provide advice training considers appropriate national recs relation performance function annual report", "start_char": 9998, "end_char": 10179, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-10", "parent_doc_id": "si-2023-0671", "section_id": "reg-10", "section_label": "Regulation 10.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "10. (1) The National Office shall make an Annual Report to the Minister", "text_raw": "10. (1) The National Office shall make an Annual Report to the Minister \non or before such date as he or she may determine and the report shall include \nsuch matters related to the National Office and National RECs as the Minister \nmay determine. \n\n(2) The National Office shall make available a copy of each annual report \n\non its website. \n\nPART 3 \n\nESTABLISHMENT OF NATIONAL RESEARCH ETHICS \nCOMMITTEES FOR CLINICAL INVESTIGATIONS \n\nEstablishment and functions of national research ethics committee", "text_norm": "10 (1) national office shall make annual report minister date may determine report shall include matter related national office national recs minister may determine (2) national office shall make available copy annual report website part 3 establishment national research ethic committee clinical investigation establishment function national research ethic committee", "start_char": 10179, "end_char": 10683, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-11", "parent_doc_id": "si-2023-0671", "section_id": "reg-11", "section_label": "Regulation 11.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "11. The Minister may, from time to time, establish one or more than", "text_raw": "11. The Minister may, from time to time, establish one or more than \n\none, National Research Ethics Committees (each of which shall, in these \nRegulations, be referred to as a National REC) to perform ethical reviews and \nprovide opinions on clinical investigations under the EU Regulation. \n\nMembership and operation of National RECs", "text_norm": "11 minister may time time establish one one national research ethic committee (each shall regulation referred national rec) perform ethical review provide opinion clinical investigation eu regulation membership operation national recs", "start_char": 10683, "end_char": 11020, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-12", "parent_doc_id": "si-2023-0671", "section_id": "reg-12", "section_label": "Regulation 12.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "12. (1) The Minister shall, subject to this Regulation and the Schedule,", "text_raw": "12. (1) The Minister shall, subject to this Regulation and the Schedule, \n\nappoint the members of a National REC. \n\n(2) A National REC shall consist of expert members and lay members who, \nhaving regard to the functions of the National REC concerned, are suitably \nqualified in terms of diversity of skills, qualifications, interests and backgrounds \nto form opinions on applications likely to be made to the National REC under \n\n \n \n \n \n \n \n \n \n\f[671] 7 \n\nPart 4 and, in relation to lay members, particular regard shall be given to \nindividuals who are patients or representatives of patient organisations. \n\n(3) The Schedule shall apply to the membership and operation of a \n\nNational REC. \n\n(4) The Minister may – \n\n(a) \n\n(b) \n\n(c) \n\ndirect the Head of the National Office to publicly invite \nexpressions of interest from persons who may be interested in \nbeing appointed as a member of a National REC, \n\nset a deadline for the receipt of expression of interests under \nsubparagraph (a), and \n\nissue such guidance to the Head of the National Office as the \nMinister considers appropriate relating to the matters provided \nfor in this Regulation. \n\n(5) Where, after consideration of any expressions of interest made under \nparagraph (4), the Head of the National Office is of the view that it is \nnecessary, in order to ensure that a National REC has an appropriate \nmembership composition, to invite one or more other persons (including, \nwhere appropriate, persons residing outside the State) having particular skills, \nqualifications, interests or backgrounds to be considered by the Minister for \nmembership of the National REC, the Head of the National Office shall invite \nsuch persons as he or she considers appropriate to make an expression of \ninterest within such period as he or she considers appropriate. \n\n(6) The Head of the National Office shall forward the Minister for \nconsideration for appointment to a National REC the relevant details of persons \nwho – \n\n(a) \n\n(b) \n\nexpressed an interest under paragraph (4), or \n\nexpressed an interest following an invitation under paragraph \n(5), and who, in the opinion of the Head of the National Office, \nare suitably qualified \nterms of diversity of skills, \nqualifications, interests and backgrounds to form opinions on \napplications likely to be made to the National REC under Part 4. \n\nin \n\n(7) The Minister shall not appoint a person to be a member of a National \nREC unless the Minister is satisfied that the person is a fit and proper person to \nbe so appointed. \n\nProhibition on seeking or receiving payments or benefits", "text_norm": "12 (1) minister shall subject regulation schedule appoint member national rec (2) national rec shall consist expert member lay member regard function national rec concerned suitably qualified term diversity skill qualification interest background form opinion application likely made national rec 671 7 part 4 relation lay member particular regard shall given individual patient representative patient organisation (3) schedule shall apply membership operation national rec (4) minister may - (a) (b) (c) direct head national office publicly invite expression interest person may interested appointed member national rec set deadline receipt expression interest subparagraph (a) issue guidance head national office minister considers appropriate relating matter provided regulation (5) consideration expression interest made paragraph (4) head national office view necessary order ensure national rec appropriate membership composition invite one person (including appropriate person residing outside state) particular skill qualification interest background considered minister membership national rec head national office shall invite person considers appropriate make expression interest within period considers appropriate (6) head national office shall forward minister consideration appointment national rec relevant detail person - (a) (b) expressed interest paragraph (4) expressed interest following invitation paragraph (5) opinion head national office suitably qualified term diversity skill qualification interest background form opinion application likely made national rec part 4 (7) minister shall appoint person member national rec unless minister satisfied person fit proper person appointed prohibition seeking receiving payment benefit", "start_char": 11020, "end_char": 13613, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-13", "parent_doc_id": "si-2023-0671", "section_id": "reg-13", "section_label": "Regulation 13.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "13. (1) Subject to paragraph (2) of this Regulation and paragraph 7 of the", "text_raw": "13. (1) Subject to paragraph (2) of this Regulation and paragraph 7 of the \n\nSchedule, a member of a National REC may not seek or receive any payment, \nfee, financial or other benefit from a person in respect of any application made \nunder Part 4 and considered by that National REC. \n\n(2) Where a member of a National REC receives any payment, fee, \nfinancial or other benefit from a person in respect of any application made \nunder Part 4 and considered by the National REC of which he or she is a \n\n \n \n \n\f8 [671] \n\nmember, the member shall return it to the person concerned and shall, as soon \nas practicable, advise the National Office accordingly. \n\nSub-committees of National RECs", "text_norm": "13 (1) subject paragraph (2) regulation paragraph 7 schedule member national rec may seek receive payment fee financial benefit person respect application made part 4 considered national rec (2) member national rec receives payment fee financial benefit person respect application made part 4 considered national rec 8 671 member member shall return person concerned shall soon practicable advise national office accordingly sub-committees national recs", "start_char": 13613, "end_char": 14303, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-14", "parent_doc_id": "si-2023-0671", "section_id": "reg-14", "section_label": "Regulation 14.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "14. (1) The Head of the National Office may, after consulting with the", "text_raw": "14. (1) The Head of the National Office may, after consulting with the \nchairperson of a National REC, convene one or more sub-committees of a \nNational REC (in this Regulation referred to as a National REC subcommittee) to provide advice and assistance to the National REC in the \ncarrying out of its work. \n\n(2) Each member of a National REC sub-committee shall be a member of \n\nthe National REC concerned. \n\n(3) The Head of the National Office may, after consulting the chairperson \nof the National REC concerned, at any time, dissolve a National REC subcommittee. \n\n(4) A National REC sub-committee may not consider an application made \nunder these Regulations for an initial proposal to carry out a clinical \ninvestigation in the State. \n\n(5) Subject to paragraph (6), a National REC sub-committee may consider \nand make a decision on a proposal referred to the National REC under \nRegulation 15(2) for an ethical opinion on a substantial modification of a \nclinical investigation under the EU Regulation. \n\n(6) A National REC sub-committee may consider and make a decision \nreferred to in paragraph (5) only where the sub-committee concerned is chaired \nfor such consideration by – \n\n(a) \n\nthe chairperson or, in his or her absence, a deputy chairperson of \nthe National REC concerned, or \n\n(b) where neither the chairperson nor the deputy chairperson is \navailable, another member of the National REC concerned who \nis designated by the chairperson to chair that meeting. \n\nAPPLICATIONS TO AND DECISIONS OF NATIONAL RESEARCH \nETHICS COMMITTEES \n\nPART 4 \n\nReferral of a proposal to a National REC", "text_norm": "14 (1) head national office may consulting chairperson national rec convene one sub-committees national rec (in regulation referred national rec subcommittee) provide advice assistance national rec carrying work (2) member national rec sub-committee shall member national rec concerned (3) head national office may consulting chairperson national rec concerned time dissolve national rec subcommittee (4) national rec sub-committee may consider application made regulation initial proposal carry clinical investigation state (5) subject paragraph (6) national rec sub-committee may consider make decision proposal referred national rec regulation 15(2) ethical opinion substantial modification clinical investigation eu regulation (6) national rec sub-committee may consider make decision referred paragraph (5) sub-committee concerned chaired consideration - (a) chairperson absence deputy chairperson national rec concerned (b) neither chairperson deputy chairperson available another member national rec concerned designated chairperson chair meeting application decision national research ethic committee part 4 referral proposal national rec", "start_char": 14303, "end_char": 15908, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-15", "parent_doc_id": "si-2023-0671", "section_id": "reg-15", "section_label": "Regulation 15.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "15. (1) A sponsor proposing to carry out a clinical investigation in the", "text_raw": "15. (1) A sponsor proposing to carry out a clinical investigation in the \n\nState under the EU Regulation or to introduce a substantial modification to \nsuch a clinical investigation shall submit an application to the National Office. \n\n(2) Where a complete application, including such fees as are payable, has \nbeen received under paragraph (1), the National Office shall refer the \napplication to a nominated National REC for a decision on the ethical aspects \n\n \n \n \n \n \n\f[671] 9 \n\nof the proposed clinical investigation or the ethical aspects of the proposed \nsubstantial modification of a clinical investigation, as appropriate. \n\n(3) A National REC may consider only applications referred to it under \n\nparagraph (2) and any matters relating to, or arising from, such applications. \n\n(4) The National Office shall put in place such procedures, including \nelectronic procedures, as it considers appropriate to facilitate the referral of a \nproposal for consideration by a National REC under paragraph (2). \n\n(5) An application under paragraph (1) shall be— \n\n(a) \n\nsubmitted no later than the time of submission of the application \nto the Authority for authorisation or notification of the clinical \ninvestigation, \n\n(b) made in the form and manner specified by the National Office, \n\nand \n\n(c) \n\naccompanied by the specified fee, if any. \n\n(6) The National Office shall ensure that the timelines for National REC \nreview are compatible with the timelines set out in the EU Regulations for the \nassessment of the application for authorisation of the clinical investigation by \nthe Authority. \n\nConsultation by National REC", "text_norm": "15 (1) sponsor proposing carry clinical investigation state eu regulation introduce substantial modification clinical investigation shall submit application national office (2) complete application including fee payable received paragraph (1) national office shall refer application nominated national rec decision ethical aspect 671 9 proposed clinical investigation ethical aspect proposed substantial modification clinical investigation appropriate (3) national rec may consider application referred paragraph (2) matter relating arising application (4) national office shall put place procedure including electronic procedure considers appropriate facilitate referral proposal consideration national rec paragraph (2) (5) application paragraph (1) shall be-- (a) submitted later time submission application authority authorisation notification clinical investigation (b) made form manner specified national office (c) accompanied specified fee any (6) national office shall ensure timeline national rec review compatible timeline set eu regulation assessment application authorisation clinical investigation authority consultation national rec", "start_char": 15908, "end_char": 17537, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-16", "parent_doc_id": "si-2023-0671", "section_id": "reg-16", "section_label": "Regulation 16.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "16. (1) For the purposes of considering a proposal referred to it under", "text_raw": "16. (1) For the purposes of considering a proposal referred to it under \n\nRegulation 15, (in particular in respect of a proposal concerning vulnerable \npopulations where specific consideration is required pursuant to Articles 64, 65 \nand 66 of the EU Regulation) a National REC may, where it considers that the \nmembers of the National REC do not have the necessary expertise required to \nadvise on the proposal concerned, consult a person who is not a member of the \nNational REC where it is satisfied that that person has the relevant expertise \nrequired to consider the proposal. \n\n(2) The views of a person consulted under paragraph (1) shall be recorded \n\nin the minutes of the meeting by the National REC at which the proposal \nconcerned is considered. \n\n(3) Where a person who is consulted under paragraph (1) has an interest in, \nor association with, the proposal being considered he or she shall, as soon as he \nor she becomes aware of the interest or association, advise the National REC of \nthe interest. \n\n(4) A person who is consulted under paragraph (1) may, subject to the \n\nagreement of the National Office, be paid a fee by the National REC. \n\nEthical matters to be considered by National REC", "text_norm": "16 (1) purpose considering proposal referred regulation 15 (in particular respect proposal concerning vulnerable population specific consideration required pursuant article 64 65 66 eu regulation) national rec may considers member national rec necessary expertise required advise proposal concerned consult person member national rec satisfied person relevant expertise required consider proposal (2) view person consulted paragraph (1) shall recorded minute meeting national rec proposal concerned considered (3) person consulted paragraph (1) interest association proposal considered shall soon becomes aware interest association advise national rec interest (4) person consulted paragraph (1) may subject agreement national office paid fee national rec ethical matter considered national rec", "start_char": 17537, "end_char": 18749, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-17", "parent_doc_id": "si-2023-0671", "section_id": "reg-17", "section_label": "Regulation 17.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "17. (1) A National REC to which a proposal is referred for", "text_raw": "17. (1) A National REC to which a proposal is referred for \n\n \n \n \n \n\f10 [671] \n\nconsideration under Regulation 15 shall consider the ethical aspects of the \nclinical investigation and, subject to paragraphs (2) and (3), shall give an \nopinion on the ethical aspects of the clinical investigation or substantial \nmodification to which the proposal relates. \n\n(2) Where, following receipt of a proposal referred under Regulation 15, it \nappears to the National REC that further information is required in order to \ngive an opinion on the ethical aspects of the proposal, the National REC shall, \nadvise the National Office to request such additional information as it may \nspecify from the sponsor. \n\n(3) When considering a proposal referred to it, a National REC– \n\n(a) \n\nshall have regard to, in particular and where applicable, the \nmatters specified in paragraph (4) to the extent that they are \nconsidered relevant and necessary by the National REC to the \nproposal being considered, and \n\n(b) may have regard to any other ethical matter that the National \nREC wishes to consider, in accordance with international best \npractice in ethical reviews of clinical investigations. \n\n(4) The following matters are specified for the purposes of paragraph \n\n(3)(a): \n\n(a) whether there is compliance with the requirements of Article 62 \nof the EU Regulation as they apply to ethical considerations; \n\n(b) \n\nthe relevance of the clinical investigation and its design; \n\n(c) whether the evaluation of the anticipated benefits and risks is \n\nsatisfactory and whether the conclusions are justified; \n\n(d) whether the clinical investigation has been designed to involve as \nlittle pain, discomfort, fear and any other foreseeable risk as \npossible for the subjects, and both the risk threshold and the \ndegree of distress are specifically defined in the clinical \ninvestigation plan and constantly monitored; \n\n(e) whether any undue influence, including that of a financial nature, \nis exerted on the subject, or, where applicable, on his or her \nlegally designated representatives, to participate in the clinical \ninvestigation; \n\n(f) \n\n(g) \n\n(h) \n\n(i) \n\n(j) \n\ncompliance with the provisions for protection of subjects and \ninformed consent specified in Articles 63 to 68 of the EU \nRegulation; \n\nthe clinical investigation protocol; \n\nthe investigator’s brochure; \n\nthe suitability of the investigator and his or her supporting staff; \n\nthe quality and adequacy of the facilities for the clinical \ninvestigation; \n\n \n \n\f[671] 11 \n\n(k) \n\nthe amounts and, where appropriate, the arrangements for \nrewarding or compensating investigators and investigation \nsubjects; \n\n(l) \n\nthe arrangements for the recruitment of subjects; \n\n(m) \n\n(n) \n\n(o) \n\n(p) \n\n(q) \n\n(r) \n\nthe arrangements for the protection of investigation subjects \nprivacy and confidentiality. \n\nthe adequacy and completeness of the written information to be \ngiven and the procedure to be followed for the purpose of \nobtaining informed consent to participation in the clinical \ninvestigation; \n\nif the subjects are to include persons who because they are minors \nare incapable of giving informed consent, whether the research is \njustified having regard to Article 65 of the EU Regulation; \n\nif the subjects are to include persons who are adults and who are \nincapable by reason of physical or mental incapacity of giving \ninformed consent, whether the research is justified having regard \nto Article 64 of the EU Regulation; \n\nthe provision made for indemnity or compensation in the event of \ninjury or death attributable to the clinical investigation in \naccordance with Regulation 18; \n\nthe terms of any agreement between the sponsor and the owner or \noccupier of the investigation site which are relevant to the \narrangements referred to in subparagraph (k). \n\nAssent by minor to participate in clinical investigation", "text_norm": "17 (1) national rec proposal referred 10 671 consideration regulation 15 shall consider ethical aspect clinical investigation subject paragraph (2) (3) shall give opinion ethical aspect clinical investigation substantial modification proposal relates (2) following receipt proposal referred regulation 15 appears national rec information required order give opinion ethical aspect proposal national rec shall advise national office request additional information may specify sponsor (3) considering proposal referred national rec- (a) shall regard particular applicable matter specified paragraph (4) extent considered relevant necessary national rec proposal considered (b) may regard ethical matter national rec wish consider accordance international best practice ethical review clinical investigation (4) following matter specified purpose paragraph (3)(a) (a) whether compliance requirement article 62 eu regulation apply ethical consideration (b) relevance clinical investigation design (c) whether evaluation anticipated benefit risk satisfactory whether conclusion justified (d) whether clinical investigation designed involve little pain discomfort fear foreseeable risk possible subject risk threshold degree distress specifically defined clinical investigation plan constantly monitored (e) whether undue influence including financial nature exerted subject applicable legally designated representative participate clinical investigation (f) (g) (h) (i) (j) compliance provision protection subject informed consent specified article 63 68 eu regulation clinical investigation protocol investigator brochure suitability investigator supporting staff quality adequacy facility clinical investigation 671 11 (k) amount appropriate arrangement rewarding compensating investigator investigation subject (l) arrangement recruitment subject (m) (n) (o) (p) (q) (r) arrangement protection investigation subject privacy confidentiality adequacy completeness written information given procedure followed purpose obtaining informed consent participation clinical investigation subject include person minor incapable giving informed consent whether research justified regard article 65 eu regulation subject include person adult incapable reason physical mental incapacity giving informed consent whether research justified regard article 64 eu regulation provision made indemnity compensation event injury death attributable clinical investigation accordance regulation 18 term agreement sponsor owner occupier investigation site relevant arrangement referred subparagraph (k) assent minor participate clinical investigation", "start_char": 18749, "end_char": 22626, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-18", "parent_doc_id": "si-2023-0671", "section_id": "reg-18", "section_label": "Regulation 18.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "18. (1) For the purposes of Article 63(7) of the EU Regulation, in addition", "text_raw": "18. (1) For the purposes of Article 63(7) of the EU Regulation, in addition \nto the informed consent given by a guardian, a minor who is capable of \nforming an opinion and assessing the information given to him or her, shall \nalso assent in order to participate in a clinical investigation. \n\nDamage compensation in clinical investigations", "text_norm": "18 (1) purpose article 63(7) eu regulation addition informed consent given guardian minor capable forming opinion assessing information given shall also assent order participate clinical investigation damage compensation clinical investigation", "start_char": 22626, "end_char": 22968, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-19", "parent_doc_id": "si-2023-0671", "section_id": "reg-19", "section_label": "Regulation 19.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "19. A clinical investigation shall not be approved under these Regulations or", "text_raw": "19. A clinical investigation shall not be approved under these Regulations or \nconducted unless there is in place a policy of insurance or indemnity scheme to \nprovide compensation for any damage suffered by a subject resulting from \nparticipation in the clinical investigation, which policy or scheme shall be \nappropriate to the nature and the extent of the risk. \n\nConsideration of proposals by National REC", "text_norm": "19 clinical investigation shall approved regulation conducted unless place policy insurance indemnity scheme provide compensation damage suffered subject resulting participation clinical investigation policy scheme shall appropriate nature extent risk consideration proposal national rec", "start_char": 22968, "end_char": 23381, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-20", "parent_doc_id": "si-2023-0671", "section_id": "reg-20", "section_label": "Regulation 20.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "20. For the purposes of the effective and efficient consideration of", "text_raw": "20. For the purposes of the effective and efficient consideration of \nproposals referred to it under Regulation 15 the chairperson of a National REC, \nfollowing consultation with the deputy chairpersons and the Head of the \nNational Office shall, with a view to maximising the efficiency of the operation \n\n \n \n \n \n \n\f12 [671] \n\nthe National REC determine procedures for \n\nof \nprioritisation of the work of the National REC. \n\nthe organisation and \n\nDecisions on applications", "text_norm": "20 purpose effective efficient consideration proposal referred regulation 15 chairperson national rec following consultation deputy chairperson head national office shall view maximising efficiency operation 12 671 national rec determine procedure prioritisation work national rec organisation decision application", "start_char": 23381, "end_char": 23859, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-21", "parent_doc_id": "si-2023-0671", "section_id": "reg-21", "section_label": "Regulation 21.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "21. (1) A National REC, having had regard to such matters referred to in", "text_raw": "21. (1) A National REC, having had regard to such matters referred to in \nparagraph (4) of Regulation 17 as are appropriate to the proposal being \nconsidered, shall make a decision – \n\n(a) \n\n(b) \n\nto give a favourable opinion in relation to the proposal, \n\nto give a favourable opinion in relation to the proposal, subject \nto certain conditions, or \n\n(c) \n\nto refuse to give a favourable opinion in relation to the proposal. \n\n(2) The National Office shall record the decision of the National REC \nmade under paragraph (1) and shall notify the decision, including the reasons \nfor the decision, to the applicant and the Authority, as appropriate. \n\nEffect of a favourable opinion under Regulation 21", "text_norm": "21 (1) national rec regard matter referred paragraph (4) regulation 17 appropriate proposal considered shall make decision - (a) (b) give favourable opinion relation proposal give favourable opinion relation proposal subject certain condition (c) refuse give favourable opinion relation proposal (2) national office shall record decision national rec made paragraph (1) shall notify decision including reason decision applicant authority appropriate effect favourable opinion regulation 21", "start_char": 23859, "end_char": 24562, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-22", "parent_doc_id": "si-2023-0671", "section_id": "reg-22", "section_label": "Regulation 22.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "22. (1) Where an application has received a decision to give a favourable", "text_raw": "22. (1) Where an application has received a decision to give a favourable \nopinion under Regulation 21(1)(a) or (b) that decision shall have effect in every \nclinical investigation site in the State specified in the application and the \nclinical investigation can commence once all other requirements under the EU \nRegulation are met by the sponsor, including authorisation by or notification to \nthe Authority, as appropriate. \n\n(2) An institution, or a research ethics committee established or \n\njointly established by such an institution shall not request or require, as a \ncondition of research being carried out in that institution, that any examination \nof the matters referred to in Regulation 17 be carried out. \n\n(3) Where an institution or research ethics committee referred to \n\nin paragraph (2) makes a request or imposes a requirement of the nature \nspecified in paragraph (2), the sponsor whose clinical investigation has been \nthe subject of a decision under Regulation 21(1) (a) or (b) shall notify the \nNational Office of such a request or requirement. \n\n(4) Upon receipt of a notification under paragraph (3), the \n\nNational Office shall contact the institution or research ethics committee \nconcerned and request such information as it considers appropriate and the \ninstitution or research ethics committee shall co-operate with any such request. \n\n(5) An institution or a research ethics committee established or jointly \nestablished by such an institution shall not give or purport to give an ethical \nopinion for the purposes of the EU Regulation. \n\n(6) A decision under Regulation 21(1) (a) or (b) shall not be construed as \nauthorising the conduct of a clinical investigation under the EU Regulation in \nany investigation site without the approval of the institution in which the \ninvestigation site is located. \n\n \n \n \n \n\f[671] 13 \n\nApplication for consent declaration", "text_norm": "22 (1) application received decision give favourable opinion regulation 21(1)(a) (b) decision shall effect every clinical investigation site state specified application clinical investigation commence requirement eu regulation met sponsor including authorisation notification authority appropriate (2) institution research ethic committee established jointly established institution shall request require condition research carried institution examination matter referred regulation 17 carried out (3) institution research ethic committee referred paragraph (2) make request imposes requirement nature specified paragraph (2) sponsor whose clinical investigation subject decision regulation 21(1) (a) (b) shall notify national office request requirement (4) upon receipt notification paragraph (3) national office shall contact institution research ethic committee concerned request information considers appropriate institution research ethic committee shall co-operate request (5) institution research ethic committee established jointly established institution shall give purport give ethical opinion purpose eu regulation (6) decision regulation 21(1) (a) (b) shall construed authorising conduct clinical investigation eu regulation investigation site without approval institution investigation site located 671 13 application consent declaration", "start_char": 24562, "end_char": 26459, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-23", "parent_doc_id": "si-2023-0671", "section_id": "reg-23", "section_label": "Regulation 23.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "23. A sponsor making an application under this Part shall indicate, as part", "text_raw": "23. A sponsor making an application under this Part shall indicate, as part \n\nof the application, whether or not it is intended to make an application for a \nconsent declaration to the Committee appointed by the Minister under Regulation 7 of \nthe Data Protection Act 2018 (Section 36(2)) (Health Research) Regulations 2018 (S.I. No. \n314 of 2018). \n\nPART 5 \n\nAPPEALS \n\nAppealing a decision made under Regulation 21", "text_norm": "23 sponsor making application part shall indicate part application whether intended make application consent declaration committee appointed minister regulation 7 data protection act 2018 (section 36(2)) (health research) regulation 2018 (s.i no 314 2018) part 5 appeal appealing decision made regulation 21", "start_char": 26459, "end_char": 26877, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-24", "parent_doc_id": "si-2023-0671", "section_id": "reg-24", "section_label": "Regulation 24.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "24. A sponsor (in this Part referred to as the “appellant”) may, not later than", "text_raw": "24. A sponsor (in this Part referred to as the “appellant”) may, not later than \n\n30 days \n\nafter the date on which the sponsor was given notice of a decision issued by a \nNational REC under Regulation 21, submit an appeal to the National Office \nagainst that decision. \n\nEstablishment of appeal panel", "text_norm": "24 sponsor (in part referred appellant ) may later 30 day date sponsor given notice decision issued national rec regulation 21 submit appeal national office decision establishment appeal panel", "start_char": 26877, "end_char": 27181, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-25", "parent_doc_id": "si-2023-0671", "section_id": "reg-25", "section_label": "Regulation 25.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "25. (1) Where an appeal relating to the decision of a National REC under", "text_raw": "25. (1) Where an appeal relating to the decision of a National REC under \nRegulation 21(1)(c) is submitted under Regulation 24, the National Office shall \nestablish a panel (in this Part referred to as an “appeal panel”) of persons who \nare suitably qualified in terms of diversity of skills, qualifications, interests and \nbackgrounds to form opinions for the purposes of hearing and determining \nsuch an appeal. \n\n(2) Where the National Office considers it appropriate, in all the \ncircumstances, an appeal panel may hear and determine more than one appeal. \n\n(3) \n\n(a) An appeal panel established under paragraph (1) shall consist of \n\nnot \n\nless than 7 and not more than 11 members each of whom, in the opinion of the \nHead of the National Office having regard to the functions of the appeal panel, \nis suitably qualified to hear the appeal. \n\n(b) The Head of the National Office shall appoint one of the \n\nmembers of the appeal panel to be its chairperson. \n\n(c) None of the members appointed to an appeal panel shall be a \nmember of the National REC that was involved in considering \nthe application which is the subject of the appeal. \n\n(d) An appeal panel shall determine its own procedure. \n\n(e) An appellant shall provide such written information (including \nany documentation) relevant to the appeal that the appeal panel \nrequests within the period specified by the appeal panel. \n\n(f) An appeal panel – \n\n \n \n \n \n \n\f14 [671] \n\n(i) \n\nshall request the National REC that made the decision to \nforward observations, if any, in relation to an appeal \nbefore it, including on any documentation or other written \ninformation provided to the appeal panel by the appellant \nthat was not provided to the National REC when it was \nconsidering the application the subject of the appeal \nconcerned, \n\n(ii) may invite submissions from any person whom it \n\nconsiders appropriate, and \n\n(iii) may consult any person whom it believes could assist in \n\nthe consideration of the appeal. \n\n(4) The National Office shall provide such administrative and secretarial \nsupport to the appeal panel as it requires to discharge its role efficiently and \neffectively. \n\nHearing an appeal", "text_norm": "25 (1) appeal relating decision national rec regulation 21(1)(c) submitted regulation 24 national office shall establish panel (in part referred appeal panel ) person suitably qualified term diversity skill qualification interest background form opinion purpose hearing determining appeal (2) national office considers appropriate circumstance appeal panel may hear determine one appeal (3) (a) appeal panel established paragraph (1) shall consist le 7 11 member opinion head national office regard function appeal panel suitably qualified hear appeal (b) head national office shall appoint one member appeal panel chairperson (c) none member appointed appeal panel shall member national rec involved considering application subject appeal (d) appeal panel shall determine procedure (e) appellant shall provide written information (including documentation) relevant appeal appeal panel request within period specified appeal panel (f) appeal panel - 14 671 (i) shall request national rec made decision forward observation relation appeal including documentation written information provided appeal panel appellant provided national rec considering application subject appeal concerned (ii) may invite submission person considers appropriate (iii) may consult person belief could assist consideration appeal (4) national office shall provide administrative secretarial support appeal panel requires discharge role efficiently effectively hearing appeal", "start_char": 27181, "end_char": 29357, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-26", "parent_doc_id": "si-2023-0671", "section_id": "reg-26", "section_label": "Regulation 26.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "26. (1) An appeal under Regulation 24 shall be considered by the appeal", "text_raw": "26. (1) An appeal under Regulation 24 shall be considered by the appeal \n\npanel as \n\nsoon as practicable following the establishment of the appeal panel under \nparagraph (1) of Regulation 25. \n\n(2) \n\n(a) The appeal panel shall, in hearing an appeal, have regard to \nsome or all of the matters set out in Regulation 17(4) to the \nextent that the appeal panel consider them appropriate to the \nparticular appeal being heard. \n\n(b) Having considered an appeal, the appeal panel shall – \n\n(i) \n\nconfirm the decision under Regulation 21(1)(c), or \n\n(ii) \n\nallow the appeal, \n\nand shall as soon as practicable notify the National Office. \n\n(c) After receiving a notification under subparagraph (b), the \nNational Office shall notify the decision, including the reasons \nfor the decision, to the appellant and the Authority, as \nappropriate \n\nDissolution of appeal panel", "text_norm": "26 (1) appeal regulation 24 shall considered appeal panel soon practicable following establishment appeal panel paragraph (1) regulation 25 (2) (a) appeal panel shall hearing appeal regard matter set regulation 17(4) extent appeal panel consider appropriate particular appeal heard (b) considered appeal appeal panel shall - (i) confirm decision regulation 21(1)(c) (ii) allow appeal shall soon practicable notify national office (c) receiving notification subparagraph (b) national office shall notify decision including reason decision appellant authority appropriate dissolution appeal panel", "start_char": 29357, "end_char": 30223, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-27", "parent_doc_id": "si-2023-0671", "section_id": "reg-27", "section_label": "Regulation 27.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "27. An appeal panel, having considered the appeal or appeals in relation to", "text_raw": "27. An appeal panel, having considered the appeal or appeals in relation to \n\nwhich \n\nit has been established under Regulation 25 and having made a decision or \ndecisions and notified the National Office under Regulation 26, shall stand \ndissolved 30 working days after it has made such notifications. \n\n \n \n \n \n \n \n\f[671] 15 \n\nAllowances for reasonable expenses", "text_norm": "27 appeal panel considered appeal appeal relation established regulation 25 made decision decision notified national office regulation 26 shall stand dissolved 30 working day made notification 671 15 allowance reasonable expense", "start_char": 30223, "end_char": 30588, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-28", "parent_doc_id": "si-2023-0671", "section_id": "reg-28", "section_label": "Regulation 28.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "28. There may be paid by the Minister to the members of an appeal panel", "text_raw": "28. There may be paid by the Minister to the members of an appeal panel \nsuch allowances in respect of reasonable expenses properly incurred by them in \nthe performance of their functions as the Minister may, with the consent of the \nMinister for Public Expenditure and Reform, determine. \n\nCO-OPERATION BETWEEN NATIONAL OFFICE, NATIONAL REC \nAND AUTHORITY \n\nPART 6 \n\nCo-operation: general", "text_norm": "28 may paid minister member appeal panel allowance respect reasonable expense properly incurred performance function minister may consent minister public expenditure reform determine co-operation national office national rec authority part 6 co-operation general", "start_char": 30588, "end_char": 30980, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-29", "parent_doc_id": "si-2023-0671", "section_id": "reg-29", "section_label": "Regulation 29.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "29. The National Office, the Authority and each National REC shall cooperate with each other and assist each other in the performance of their", "text_raw": "29. The National Office, the Authority and each National REC shall cooperate with each other and assist each other in the performance of their \nrespective functions in order to give full effect to the EU Regulation in the \nState. \n\nCo-operation on specific matters", "text_norm": "29 national office authority national rec shall cooperate assist performance respective function order give full effect eu regulation state co-operation specific matter", "start_char": 30980, "end_char": 31247, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-30", "parent_doc_id": "si-2023-0671", "section_id": "reg-30", "section_label": "Regulation 30.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "30. Without prejudice to the generality of Regulation 29, the National", "text_raw": "30. Without prejudice to the generality of Regulation 29, the National \n\nOffice, on behalf of National RECs, and the Authority shall, as appropriate, – \n\n(a) \n\n(b) \n\nco-ordinate the review of applications under these Regulations \nand the validation and assessment of the applications for \nsubstantial \nauthorisation of clinical \nmodifications to clinical investigations, including timelines, \n\ninvestigations \n\nand \n\nco-operate in relation to the performance of tasks relating to a \ntimelines and \nin accordance with \nclinical \nprocedures provided for in the EU Regulation, \n\ninvestigation \n\n(c) \n\nco-operate, where appropriate, in the monitoring of clinical \ninvestigations commenced in the State under the EU Regulation. \n\nCo-operation: Memorandum of Understanding", "text_norm": "30 without prejudice generality regulation 29 national office behalf national recs authority shall appropriate - (a) (b) co-ordinate review application regulation validation assessment application substantial authorisation clinical modification clinical investigation including timeline investigation co-operate relation performance task relating timeline accordance clinical procedure provided eu regulation investigation (c) co-operate appropriate monitoring clinical investigation commenced state eu regulation co-operation memorandum understanding", "start_char": 31247, "end_char": 32016, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-31", "parent_doc_id": "si-2023-0671", "section_id": "reg-31", "section_label": "Regulation 31.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "31. (1) For the purposes of giving effect to Regulations 29 and 30, the", "text_raw": "31. (1) For the purposes of giving effect to Regulations 29 and 30, the \n\nNational \n\nOffice and the Authority may, from time to time, enter into a Memorandum of \nUnderstanding. \n\n(2) A Memorandum of Understanding that has been entered into under \n\nParagraph (1) may, from time to time, be amended by the National Office and \nthe Authority. \n\n(3) A Memorandum of Understanding that has been entered into under \n\n Paragraph (1) or amended under paragraph (2) shall be made available on the \nwebsite of the National Office and the website of the Authority. \n\n \n \n \n \n \n \n \n\f16 [671] \n\nPART 7 \n\nOFFENCES \n\nOffences", "text_norm": "31 (1) purpose giving effect regulation 29 30 national office authority may time time enter memorandum understanding (2) memorandum understanding entered paragraph (1) may time time amended national office authority (3) memorandum understanding entered paragraph (1) amended paragraph (2) shall made available website national office website authority 16 671 part 7 offence offence", "start_char": 32016, "end_char": 32629, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-32", "parent_doc_id": "si-2023-0671", "section_id": "reg-32", "section_label": "Regulation 32.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "32. (1) A person who—", "text_raw": "32. (1) A person who— \n\na. \n\nb. \n\nc. \n\nd. \n\ne. \n\nconducts a clinical investigation to which the EU Regulation \napplies contrary to an opinion or appeal decision under these \nRegulations \nfor such clinical \ninvestigation, \n\nrefusing ethical approval \n\nintroduces a modification to a clinical investigation to which \nArticle 75 of the EU Regulation applies without applying for and \nbeing granted approval for such modification under these \nRegulations, \n\ninvestigation approved under \n\nthese \nconducts a clinical \nRegulations without there being in place a policy of insurance or \nindemnity scheme to provide compensation for any damage \nsuffered by a subject resulting from participation in such clinical \ninvestigation in accordance with Regulation 19, \n\nin the course of an application or appeal under these Regulations, \nor the monitoring of a clinical investigation approved under these \nRegulations, makes any statement or representation, whether oral \nor written, that he or she knows to be false or misleading in any \nmaterial respect to a National REC, or \n\nknowingly makes any statement or representation, whether oral \nor written, that a clinical investigation that he or she is carrying \nout, or is planning to carry out or has carried out, has been \napproved by a National REC or an appeal panel if he or she knows \nthe statement or representation to be false or misleading, \n\nis guilty of an offence. \n\nPenalties and prosecution of offences", "text_norm": "32 (1) person who-- a b c d e conduct clinical investigation eu regulation applies contrary opinion appeal decision regulation clinical investigation refusing ethical approval introduces modification clinical investigation article 75 eu regulation applies without applying granted approval modification regulation investigation approved conduct clinical regulation without place policy insurance indemnity scheme provide compensation damage suffered subject resulting participation clinical investigation accordance regulation 19 course application appeal regulation monitoring clinical investigation approved regulation make statement representation whether oral written know false misleading material respect national rec knowingly make statement representation whether oral written clinical investigation carrying planning carry carried approved national rec appeal panel know statement representation false misleading guilty offence penalty prosecution offence", "start_char": 32629, "end_char": 34085, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-33", "parent_doc_id": "si-2023-0671", "section_id": "reg-33", "section_label": "Regulation 33.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "33. (1) A person who commits an offence under these Regulations is", "text_raw": "33. (1) A person who commits an offence under these Regulations is \n\nliable— \n\n(a) \n\non a summary conviction, to a class B fine or imprisonment for a \nterm not exceeding 6 months, or both, or \n\n(b) on conviction on indictment, to a fine not exceeding €300,000 or \n\nimprisonment for a term not exceeding 3 years, or both. \n\n(2) Proceedings in relation to a summary offence under these Regulations \n\nmay be prosecuted by the Minister. \n\n \n \n \n \n \n \n \n\f[671] 17 \n\nPART 8 \n\nAMENDMENT OF THE HEALTH RESEARCH BOARD \n(ESTABLISHMENT) ORDER 1986 \n\nAmendment of the Health Research Board (Establishment) Order 1986", "text_norm": "33 (1) person commits offence regulation liable-- (a) summary conviction class b fine imprisonment term exceeding 6 month (b) conviction indictment fine exceeding eur300 000 imprisonment term exceeding 3 year both (2) proceeding relation summary offence regulation may prosecuted minister 671 17 part 8 amendment health research board (establishment) order 1986 amendment health research board (establishment) order 1986", "start_char": 34085, "end_char": 34692, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-34", "parent_doc_id": "si-2023-0671", "section_id": "reg-34", "section_label": "Regulation 34.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "34. Article 4 of the Health Research Board (Establishment) Order 1986 (SI", "text_raw": "34. Article 4 of the Health Research Board (Establishment) Order 1986 (SI \n\nNo. \n\n279 of 1986) is amended, in paragraph (1), by the insertion of the following \nsubparagraph after subparagraph (f): \n\n“(g) to carry out the functions conferred on the Board (including the \nfunctions conferred on the unit within the Board known as the National \nOffice for National Research Ethics Committees for Clinical Investigations \nof Medical Devices by the European Union (National Research Ethics \nCommittees for Clinical Investigations of Medical Devices) Regulations", "text_norm": "34 article 4 health research board (establishment) order 1986 (si no 279 1986) amended paragraph (1) insertion following subparagraph subparagraph (f) (g) carry function conferred board (including function conferred unit within board known national office national research ethic committee clinical investigation medical device european union (national research ethic committee clinical investigation medical devices) regulation", "start_char": 34692, "end_char": 35250, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-2023", "parent_doc_id": "si-2023-0671", "section_id": "reg-2023", "section_label": "Regulation 2023.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "2023.”.", "text_raw": "2023.”. \n\nFees", "text_norm": "2023  fee", "start_char": 35250, "end_char": 35267, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-35", "parent_doc_id": "si-2023-0671", "section_id": "reg-35", "section_label": "Regulation 35.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "35. (1) Subject to paragraph (2), the following fees shall be payable by", "text_raw": "35. (1) Subject to paragraph (2), the following fees shall be payable by \n\na sponsor to the National Office : \n\n(a) \n\n€1,500 in respect of each application for National REC review \nrelating to the conduct of a clinical investigation in the State, \n\n(b) €300 in respect of each application for National REC review of a \n\nsubstantial modification of a clinical investigation, and \n\n(c) \n\n€1,200 in respect of each appeal under Regulation 24 (which \nfee shall be refundable if the appeal is successful). \n\n(2) Paragraph (1) does not apply to applications relating to a non-commercial \n\nclinical investigations. \n\n(3) The National Office may recover, as a simple contract debt in any court \nof competent jurisdiction, from the person by whom it is payable, any amount \ndue and owing to it as a fee payable under this Regulation. \n\nREVOCATIONS AND TRANSITIONAL PROVISIONS \n\nPART 9 \n\nRevocations", "text_norm": "35 (1) subject paragraph (2) following fee shall payable sponsor national office (a) eur1 500 respect application national rec review relating conduct clinical investigation state (b) eur300 respect application national rec review substantial modification clinical investigation (c) eur1 200 respect appeal regulation 24 (which fee shall refundable appeal successful) (2) paragraph (1) apply application relating non-commercial clinical investigation (3) national office may recover simple contract debt court competent jurisdiction person payable amount due owing fee payable regulation revocation transitional provision part 9 revocation", "start_char": 35267, "end_char": 36159, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-36", "parent_doc_id": "si-2023-0671", "section_id": "reg-36", "section_label": "Regulation 36.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "36. (1) The following regulations are revoked:", "text_raw": "36. (1) The following regulations are revoked: \n\n(a) The Regulations of 2021; \n\n(b) European Union (National Research Ethics Committee for \nClinical Investigations of Medical Devices) (Amendment) \nRegulations 2022 (S.I. 726/2022). \n\n \n \n \n \n \n \n\f18 [671] \n\nTransitional", "text_norm": "36 (1) following regulation revoked (a) regulation 2021 (b) european union (national research ethic committee clinical investigation medical devices) (amendment) regulation 2022 (s.i 726 2022) 18 671 transitional", "start_char": 36159, "end_char": 36431, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-37", "parent_doc_id": "si-2023-0671", "section_id": "reg-37", "section_label": "Regulation 37.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "37. (1) Notwithstanding the revocation of the Regulations of 2021 by", "text_raw": "37. (1) Notwithstanding the revocation of the Regulations of 2021 by \n\nRegulation 36: \n\n(a) \n\n(b) \n\n(c) \n\na National REC established under the Regulations of 2021, \nwhich \nthe \ncommencement of these Regulations, continues in being after \nsuch commencement, as if established under these Regulations; \n\nimmediately \n\ncontinued \n\nbefore \n\nbeing, \n\nin \n\nsub-committee established under \n\na National REC \nthe \nRegulations of 2021, which continued in being immediately \nbefore the commencement of these Regulations, continues in \nbeing after such commencement as if convened under these \nRegulations. \n\ncontinued \n\nan appeal panel established under the Regulations of 2021, \nthe \nwhich \ncommencement of these Regulations, continues in being after \nsuch commencement as if established under these Regulations; \nand \n\nimmediately \n\nbefore \n\nbeing \n\nin \n\n(d) \n\nany ethical approval granted on foot of an application or appeal \nunder the Regulations of 2021 continues to be approved as if the \napproval was granted under these Regulations. \n\n(2) \n\n(a) Where, at the date of the coming into operation of these \nRegulations, an application or appeal \nfor \nconsideration or under consideration in accordance with the \nprovisions of the Regulations of 2021, that application or appeal \nshall be deemed to be an application or appeal, as the case may \nbe, under these Regulations and these Regulations shall apply to \nthe application or appeal accordingly. \n\nis pending \n\n(b) The National Office shall, in relation to such an application or \nappeal, notify the applicant or appellant, in writing, that the \napplication or appeal, as the case may be, is being treated as if it \nwas an application or appeal made under these Regulations and \nconsidered accordingly. \n\n \n \n \n \n\f[671] 19 \n\nRegulation 12 \n\nSchedule \n\nMembership and Procedural Matters relating to National RECs \n\nMembership", "text_norm": "37 (1) notwithstanding revocation regulation 2021 regulation 36 (a) (b) (c) national rec established regulation 2021 commencement regulation continues commencement established regulation immediately continued sub-committee established national rec regulation 2021 continued immediately commencement regulation continues commencement convened regulation continued appeal panel established regulation 2021 commencement regulation continues commencement established regulation immediately (d) ethical approval granted foot application appeal regulation 2021 continues approved approval granted regulation (2) (a) date coming operation regulation application appeal consideration consideration accordance provision regulation 2021 application appeal shall deemed application appeal case may regulation regulation shall apply application appeal accordingly pending (b) national office shall relation application appeal notify applicant appellant writing application appeal case may treated application appeal made regulation considered accordingly 671 19 regulation 12 schedule membership procedural matter relating national recs membership", "start_char": 36431, "end_char": 38305, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-1", "parent_doc_id": "si-2023-0671", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "1. (1) A National REC shall have no fewer than 15 members and no more", "text_raw": "1. (1) A National REC shall have no fewer than 15 members and no more \n\nthan 28 members, including a chairperson, and 2 deputy chairpersons. \n\n(2) The chairperson, deputy chairpersons and ordinary members of a \n\nNational REC shall be appointed by the Minister. \n\n(3) A National REC shall consist of persons who in the opinion of the \nMinister, having regard to the functions of the National REC concerned, are \nsuitably qualified to serve as lay or expert members, as appropriate. \n\n(4) The members of a National REC shall be appointed by the Minister and \n\nof the members not fewer than one quarter shall be lay persons. \n\n(5) \n\n(a) The chairperson and the deputy chairpersons of a National REC \n\nshall each hold office for a period of 4 years from the date of his or her \nappointment, or such shorter period as may be determined by the Minister. \n\n(b) An ordinary member of a National REC shall hold office for a \nperiod of 3 years from the date of his or her appointment, or \nsuch shorter period as may be determined by the Minister. \n\n(c) \n\nIn determining the duration of any appointment under this \nsubparagraph, the Minister shall seek to ensure that not more \nthan one third of the membership is due to expire during any \nparticular period. \n\n(6) A member of a National REC whose term of office expires by the \n\nefflux of time shall be eligible for reappointment to the National REC.", "text_norm": "1 (1) national rec shall fewer 15 member 28 member including chairperson 2 deputy chairperson (2) chairperson deputy chairperson ordinary member national rec shall appointed minister (3) national rec shall consist person opinion minister regard function national rec concerned suitably qualified serve lay expert member appropriate (4) member national rec shall appointed minister member fewer one quarter shall lay person (5) (a) chairperson deputy chairperson national rec shall hold office period 4 year date appointment shorter period may determined minister (b) ordinary member national rec shall hold office period 3 year date appointment shorter period may determined minister (c) determining duration appointment subparagraph minister shall seek ensure one third membership due expire particular period (6) member national rec whose term office expires efflux time shall eligible reappointment national rec", "start_char": 38305, "end_char": 39698, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-2", "parent_doc_id": "si-2023-0671", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "2. (1) A member of a National REC may resign by written notice signed by", "text_raw": "2. (1) A member of a National REC may resign by written notice signed by \nhim or her to the Minister and the resignation shall take effect on the date of \nthe meeting of the National REC concerned next held after written notice of \nresignation is received by the Minister. \n\n(2) The Minister may at any time remove from office a member of a \n\nNational REC if, in the Minister’s opinion— \n\n(a) \n\n(b) \n\n(c) \n\nthe member has become \nperforming his or her functions, \n\nincapable \n\nthrough \n\nill-health of \n\nthe member has committed stated misbehaviour of a type that \nwould make him or her unsuitable for membership of the \nNational REC, or \n\nthe removal of the member appears to the Minister to be \nnecessary for the National REC to perform its functions \neffectively and with public confidence. \n\n \n \n \n \n\f20 [671] \n\n(3) If a member of a National REC dies, resigns, ceases to be qualified for \noffice and ceases to hold office, or is removed from office, the Minister may \nappoint a person to be a member to fill the casual vacancy so occasioned. \n\n \n \n\f[671] 21 \n\nA person appointed to be a member of a National REC under \n\n(4) \nsubparagraph (3) holds office for such period as the Minister may determine. \n\nMeetings", "text_norm": "2 (1) member national rec may resign written notice signed minister resignation shall take effect date meeting national rec concerned next held written notice resignation received minister (2) minister may time remove office member national rec minister opinion-- (a) (b) (c) member become performing function incapable ill-health member committed stated misbehaviour type would make unsuitable membership national rec removal member appears minister necessary national rec perform function effectively public confidence 20 671 (3) member national rec dy resigns cease qualified office cease hold office removed office minister may appoint person member fill casual vacancy occasioned 671 21 person appointed member national rec (4) subparagraph (3) hold office period minister may determine meeting", "start_char": 39698, "end_char": 40916, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-3", "parent_doc_id": "si-2023-0671", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "3. (1) The quorum for a meeting of a National REC shall be 7, and at least", "text_raw": "3. (1) The quorum for a meeting of a National REC shall be 7, and at least \none of those present shall be the chairperson or a deputy chairperson or, subject \nto paragraph 4(3)(b), where neither of the aforementioned are available, \nanother member of the National REC who is designated by the chairperson to \nchair that meeting. \n\n(2) Subject to subparagraph (1), the proceedings of a National REC shall \n\nnot be invalidated by any vacancy among its members.", "text_norm": "3 (1) quorum meeting national rec shall 7 least one present shall chairperson deputy chairperson subject paragraph 4(3)(b) neither aforementioned available another member national rec designated chairperson chair meeting (2) subject subparagraph (1) proceeding national rec shall invalidated vacancy among member", "start_char": 40916, "end_char": 41377, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-4", "parent_doc_id": "si-2023-0671", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "4. (1) (a) The chairperson or, in the absence of the chairperson, a deputy", "text_raw": "4. (1) (a) The chairperson or, in the absence of the chairperson, a deputy \n\nchairperson of a National REC, shall convene a meeting of the National REC, \nnot later than 20 working days after being advised by the National Office that \nhe or she should do so. \n\n(b) The chairperson or, in the absence of the chairperson, a deputy \n\nchairperson of a National REC may, at any time, inform the National Office, of \nhis or her intention to convene a meeting of the National REC. \n\n(2) At least 5 working days before a meeting of a National REC, the \n\nagenda \n\napproved by or on behalf of the chairperson of the National REC concerned, or \nin the absence of the chairperson, by or on behalf of a deputy chairperson, shall \nbe sent by the National Office to every member of the National REC scheduled \nto attend the meeting. \n\n(3) At a meeting of the National REC - \n\n(a) \n\n(b) \n\n the chairperson of the National REC shall, if present, be the \nchairperson of the meeting, \n\nif and so long as the office of chairperson of the National REC is \nvacant, the Head of the National Office shall nominate a deputy \nchairperson to be the chairperson of the meeting or, where a \ndeputy chairperson is not available, another member of the \nNational REC shall be designated by the Head of the National \nOffice to chair that meeting. \n\n(4) For the purposes of the effective and efficient consideration of \n\napplications \n\nreferred to it by the National Office, the chairperson of a National REC, after \nconsulting with the deputy chairpersons and the Head of the National Office, \nshall determine the best way to organise the work of the REC concerned. \n\n \n \n \n \n \n \n \n\f22 [671] \n\nDecision Making", "text_norm": "4 (1) (a) chairperson absence chairperson deputy chairperson national rec shall convene meeting national rec later 20 working day advised national office so (b) chairperson absence chairperson deputy chairperson national rec may time inform national office intention convene meeting national rec (2) least 5 working day meeting national rec agenda approved behalf chairperson national rec concerned absence chairperson behalf deputy chairperson shall sent national office every member national rec scheduled attend meeting (3) meeting national rec - (a) (b) chairperson national rec shall present chairperson meeting long office chairperson national rec vacant head national office shall nominate deputy chairperson chairperson meeting deputy chairperson available another member national rec shall designated head national office chair meeting (4) purpose effective efficient consideration application referred national office chairperson national rec consulting deputy chairperson head national office shall determine best way organise work rec concerned 22 671 decision making", "start_char": 41377, "end_char": 43055, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-5", "parent_doc_id": "si-2023-0671", "section_id": "reg-5", "section_label": "Regulation 5.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "5. (1) Where a member of a National REC has a material interest in any", "text_raw": "5. (1) Where a member of a National REC has a material interest in any \n\nmatter which falls to be considered by the National REC, he or she shall- \n\n(a) \n\ndisclose to the chairman of the National REC the nature of the \ninterest in advance of any consideration of the matter, \n\n(b) neither influence nor seek to influence a decision relating to \n\nthe matter, \n\n(c) withdraw from a meeting or that part of a meeting at which the \n\nmatter is being discussed or considered, and \n\n(d) \n\ntake no part in any deliberation or decision relating to the matter. \n\n(2) For the purposes of this paragraph, but without prejudice to the \ngenerality of subparagraph (1), a person is regarded as having a material \ninterest if— \n\n(a) \n\n(b) \n\n(c) \n\nthe person, a connected relative of the person or a nominee of \neither of them is a member of a company or any other body \nwhich has a beneficial interest in, or material to, any matter to \nbe considered under that subparagraph, \n\nthe person or a connected relative of the person is in partnership \nwith or is in the employment of a person who has a beneficial \ninterest in, or material to, any such matter, \n\nthe person or a connected relative is a party to any arrangement \nor agreement (whether or not enforceable) concerning land to \nwhich any such matter relates, or \n\n(d) \n\na connected relative has a beneficial interest in, or material to, \nany such matter. \n\n(3) For the purposes of this paragraph, a person is not regarded as having a \nmaterial interest in any matter by reason only that he or she, or any company or \nother body or person mentioned in subparagraph (2), has an interest which is so \nremote or insignificant that it cannot reasonably be regarded as likely to \ninfluence a person in considering or discussing, or in voting on, any question in \nrespect of the matter or in performing any function in relation to the matter. \n\n(4) Where a material interest is disclosed under subparagraph (1), the \ndisclosure shall be recorded in the minutes of the meeting concerned and, for so \nlong as the matter to which the disclosure relates is being dealt with by the \nmeeting, the member of the National REC by whom the disclosure is made \nshall not be counted in the quorum for the meeting. \n\n(5) Where, at a meeting of a National REC, a question arises as to whether \nor not a course of conduct, if pursued by a member of the National REC, would \nconstitute a failure by him or her to comply with the requirements of \nsubparagraph (1), the question may, subject to subparagraph (6), be determined \nby the chairperson of the meeting, whose decision shall be final, and where such \na question is so determined, particulars of the determination shall be recorded in \nthe minutes of the meeting. \n\n \n \n\f[671] 23 \n\n(6) Where, at a meeting of a National REC, the chairperson of the meeting is \nthe person in respect of whom a matter to which subparagraph (1) applies falls \nto be determined, the other members of the National REC attending the meeting \nshall choose one of their number to be chairperson of the meeting for the \npurposes of subparagraph (5). \n\n(7) Where the Minister is satisfied that a member of a National REC has \nnot complied with subparagraph (1), the Minister may remove that member \nfrom office and that person shall then be disqualified from being a member of \nthat National REC or any other National REC. \n\n(8) In this paragraph, “connected relative” in relation to a person, means a \nspouse, civil partner, parent, brother, sister, child or the spouse or civil partner \nof a child of the person. \n\n \n \n\f24 [671] \n\nMinutes", "text_norm": "5 (1) member national rec material interest matter fall considered national rec shall- (a) disclose chairman national rec nature interest advance consideration matter (b) neither influence seek influence decision relating matter (c) withdraw meeting part meeting matter discussed considered (d) take part deliberation decision relating matter (2) purpose paragraph without prejudice generality subparagraph (1) person regarded material interest if-- (a) (b) (c) person connected relative person nominee either member company body beneficial interest material matter considered subparagraph person connected relative person partnership employment person beneficial interest material matter person connected relative party arrangement agreement (whether enforceable) concerning land matter relates (d) connected relative beneficial interest material matter (3) purpose paragraph person regarded material interest matter reason company body person mentioned subparagraph (2) interest remote insignificant cannot reasonably regarded likely influence person considering discussing voting question respect matter performing function relation matter (4) material interest disclosed subparagraph (1) disclosure shall recorded minute meeting concerned long matter disclosure relates dealt meeting member national rec disclosure made shall counted quorum meeting (5) meeting national rec question arises whether course conduct pursued member national rec would constitute failure comply requirement subparagraph (1) question may subject subparagraph (6) determined chairperson meeting whose decision shall final question determined particular determination shall recorded minute meeting 671 23 (6) meeting national rec chairperson meeting person respect matter subparagraph (1) applies fall determined member national rec attending meeting shall choose one number chairperson meeting purpose subparagraph (5) (7) minister satisfied member national rec complied subparagraph (1) minister may remove member office person shall disqualified member national rec national rec (8) paragraph connected relative relation person mean spouse civil partner parent brother sister child spouse civil partner child person 24 671 minute", "start_char": 43055, "end_char": 46645, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-6", "parent_doc_id": "si-2023-0671", "section_id": "reg-6", "section_label": "Regulation 6.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "6. (1) An officer of the National Office shall attend each meeting of a", "text_raw": "6. (1) An officer of the National Office shall attend each meeting of a \nNational REC and he or she shall cause proper minutes of the meeting to be \nprepared, which shall, subject to any agreed amendments, be approved by the \nNational REC at the next meeting of the National REC concerned and, after \nthey are approved, the minutes shall be published on the website of the \nNational Office. \n\n(2) The National Office shall, when compiling minutes, have regard to \nmatters of commercial sensitivity and shall ensure that minutes published on its \nwebsite comply with the Data Protection Acts 1998 to 2018. \n\n(3) The names of all members present at a meeting of a National REC shall \n\nbe recorded in the minutes of the meeting. \n\nExpenses", "text_norm": "6 (1) officer national office shall attend meeting national rec shall cause proper minute meeting prepared shall subject agreed amendment approved national rec next meeting national rec concerned approved minute shall published website national office (2) national office shall compiling minute regard matter commercial sensitivity shall ensure minute published website comply data protection act 1998 2018 (3) name member present meeting national rec shall recorded minute meeting expense", "start_char": 46645, "end_char": 47384, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-7", "parent_doc_id": "si-2023-0671", "section_id": "reg-7", "section_label": "Regulation 7.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "7. A member of a National REC may be paid such allowances in respect", "text_raw": "7. A member of a National REC may be paid such allowances in respect \nof reasonable expenses as the Minister, with the consent of the Minister for \nPublic Expenditure and Reform, determines. \n\nProcedures", "text_norm": "7 member national rec may paid allowance respect reasonable expense minister consent minister public expenditure reform determines procedure", "start_char": 47384, "end_char": 47590, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-8", "parent_doc_id": "si-2023-0671", "section_id": "reg-8", "section_label": "Regulation 8.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "8. Subject to these Regulations, a National REC, following consultation", "text_raw": "8. Subject to these Regulations, a National REC, following consultation \nwith the National Office, shall determine its own procedures, including that a \nmember of a National REC may attend its meetings by remote means and how \ndecisions under Regulation 21 are to be made. \n\nGIVEN under my Official Seal, \n\n20 December, 2023. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\f[671] 25", "text_norm": "8 subject regulation national rec following consultation national office shall determine procedure including member national rec may attend meeting remote mean decision regulation 21 made given official seal 20 december 2023 stephen donnelly minister health 671 25", "start_char": 47590, "end_char": 48000, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-explanatory-note", "parent_doc_id": "si-2023-0671", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations revoke and replace the European Union (National Research \nEthics Committee for Clinical Investigations of Medical Devices) Regulations \n2021 (S.I. 260 of 2021), which provided for the establishment of national \nresearch ethics committees for the purpose of ethical approval of clinical \ninvestigations of medical devices. \n\nThese Regulations also revoke and replace the European Union (National \nResearch Ethics Committee for Clinical Investigations of Medical Devices) \n(Amendment) Regulations 2022 (S.I. 726/2022), which amended the amount of \nfess payable in respect of applications for national research ethics committee \nreviews and appeals in respect of such applications. \n\nIn addition to providing for the establishment of national research ethics \ncommittees for the purpose of ethical approval of clinical investigations of \nmedical devices and laying down procedures and rules that apply to applications to \nsuch committees, these Regulations provide for a National Office to administratively \nsupport the work of those committees. These Regulations also remove fees for \napplications relating to non-commercial clinical investigations. \n\nThese Regulations may be cited as the European Union (National Research \nEthics Committees for Clinical Investigations of Medical Devices) Regulations", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulation revoke replace european union (national research ethic committee clinical investigation medical devices) regulation 2021 (s.i 260 2021) provided establishment national research ethic committee purpose ethical approval clinical investigation medical device regulation also revoke replace european union (national research ethic committee clinical investigation medical devices) (amendment) regulation 2022 (s.i 726 2022) amended amount fes payable respect application national research ethic committee review appeal respect application addition providing establishment national research ethic committee purpose ethical approval clinical investigation medical device laying procedure rule apply application committee regulation provide national office administratively support work committee regulation also remove fee application relating non-commercial clinical investigation regulation may cited european union (national research ethic committee clinical investigation medical devices) regulation", "start_char": 48000, "end_char": 49435, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
{"doc_id": "si-2023-0671-reg-2023", "parent_doc_id": "si-2023-0671", "section_id": "reg-2023", "section_label": "Regulation 2023.", "si_number": "S.I. No. 671 of 2023", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2023, "heading": "26 [671]", "text_raw": "2023. \n\n \n \n \n \n \n \n \n \n\f26 [671] \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \nBÓTHAR BHAILE UÍ BHEOLÁIN, \nCILL MHAIGHNEANN, \nBAILE ÁTHA CLIATH 8, \nD08 XAO6 \n\nTeil: 046 942 3100 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \nMOUNTSHANNON ROAD, \nKILMAINHAM, DUBLIN 8, \nD08 XAO6 \n\nTel: 046 942 3100 \nE-mail: publications@opw.ie \n—————— \n\n€ 6.50 \n\n(DH-512) 75. 12/23. Propylon.", "text_norm": "2023 26 671 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais bothar bhaile ui bheolain cill mhaighneann baile atha cliath 8 d08 xao6 teil 046 942 3100 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication mountshannon road kilmainham dublin 8 d08 xao6 tel 046 942 3100 e-mail publication opw.ie ------------ eur 6.50 (dh-512) 75 12 23 propylon", "start_char": 49435, "end_char": 49955, "source_path": "downloads\\2023\\2023_0671.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7ae86c549390aacbf4d1aee5e3a3cdbf57e85a962806225e36951d391556cf8c", "cross_refs": []}
